Greenleaf Trust Acquires 694 Shares of Cardinal Health, Inc. (NYSE:CAH)

Greenleaf Trust lifted its stake in Cardinal Health, Inc. (NYSE:CAH) by 15.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,201 shares of the company’s stock after buying an additional 694 shares during the period. Greenleaf Trust’s holdings in Cardinal Health were worth $615,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in CAH. Paragon Capital Management Inc. lifted its stake in shares of Cardinal Health by 0.7% in the 3rd quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company’s stock valued at $1,642,000 after purchasing an additional 99 shares during the period. Huntington National Bank increased its holdings in Cardinal Health by 0.9% in the third quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares in the last quarter. Frazier Financial Advisors LLC lifted its stake in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares during the period. UMB Bank n.a. boosted its holdings in shares of Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock worth $249,000 after buying an additional 106 shares in the last quarter. Finally, Raleigh Capital Management Inc. grew its position in shares of Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock worth $55,000 after buying an additional 106 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $125.29 on Wednesday. The firm has a market cap of $30.27 billion, a PE ratio of 23.38, a P/E/G ratio of 1.46 and a beta of 0.63. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The stock has a fifty day moving average price of $122.16 and a 200-day moving average price of $114.75.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.92 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is currently 37.69%.

Analysts Set New Price Targets

CAH has been the topic of several research analyst reports. Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Deutsche Bank Aktiengesellschaft upped their price target on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Barclays upped their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $135.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.